Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-11-04
2000-01-04
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142378, 514321, 514356, 514640, 514647, 514649, 514654, 514657, A61K 31405, A61K 31535, A61K 31445, A61K 3144, A61K 31135
Patent
active
060110546
ABSTRACT:
The present invention relates to a method of treatment of depression in a human being identified as having depression. This method comprises the administration of a therapeutically effective depression treatment amount of N-acetyl-serotonin (NAS), also referred to as N-acetyl-5-hydroxytryptamine, to a human being identified as having depression. The NAS may be administered alone or in combination with other agents, e.g., Ca.sup.++ antagonists.
REFERENCES:
patent: 4956361 (1990-09-01), Traber et al.
patent: 5552428 (1996-09-01), Fraschini et al.
Oxenkrug Gregory F.
Requintina Pura J.
Jarvis William R. A.
Resnick David S.
St. Elizabeth's Medical Center of Boston
LandOfFree
Method for treating depression, obsessive compulsive disorder, a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating depression, obsessive compulsive disorder, a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating depression, obsessive compulsive disorder, a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072965